Priority Date: 21.03.12 (US 201261613865P)

TFPI INHIBITORS AND METHODS OF USE

  • Application ID: EP13703505
  • Status: █ GRANT OF PATENT INTENDED

Applicants

Technology company logo small
Baxter International Inc
Technology Company
Technology company logo small
Baxter Healthcare SA
Technology Company
Technology company logo small
Baxalta Incorporated
Technology Company
Technology company logo small
Baxalta GmbH
Technology Company

Attorney

Employment test 51 - 200 employees
Missing person image thumb Missing person image thumb Missing person image thumb
Company dna potter clarkson llp
operating since 1889
1071.86
Potter Clarkson LLP
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Potter Clarkson LLP is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 188 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 21.03.2012 - Priority Date (US 201261613865P)
  • 26.09.2013 - Publication A1 (WO2013141965)
  • 28.01.2015 - Publication A1 (EP2827883)

IPC Classification